Document:

EX-10.15

 Exhibit 10.15 

Execution Version 

FIRST AMENDMENT TO AMENDED AND RESTATED TERM LOAN CREDIT AGREEMENT 

FIRST AMENDMENT TO AMENDED AND RESTATED TERM LOAN CREDIT AGREEMENT, dated as of August 6, 2020 (this “Amendment”), among
CPG International LLC, a Delaware limited liability company (the “Borrower”), The AZEK Company Inc., a Delaware corporation (“Successor Holdings”), as
successor-in-interest to CPG Newco LLC, a Delaware limited liability company (“Predecessor Holdings”), the Lenders party hereto and Jefferies Finance
LLC, as administrative agent (the “Administrative Agent”) which shall amend that certain Amended and Restated Term Loan Credit Agreement, dated as of June 18, 2018, among the Borrower, Predecessor Holdings, the several lenders
from time to time party thereto (the “Lenders”), and the Administrative Agent (as in effect on the date hereof, the “Credit Agreement”). 

W I T N E S S E T H: 

WHEREAS, on June 11, 2020, Predecessor Holdings completed an initial public offering of its class A common stock (the
“IPO”), and upon the completion of the IPO, Predecessor Holdings converted into a Delaware corporation and changed its name to “The AZEK Company Inc.,” and thereafter Successor Holdings succeeded to all of the property and
assets of Predecessor Holdings and succeeded to all of the debts and obligations of Predecessor Holdings, including all obligations of Predecessor Holdings under the Credit Agreement; 

WHEREAS, following the completion of the IPO, Successor Holdings has become a reporting company under the Securities Exchange Act of 1934, as
amended, and is obligated to file periodic reports and current reports with the SEC; 
 WHEREAS, in accordance with Section 9.08 of the
Credit Agreement, the Borrower, the Required Lenders and the Administrative Agent have agreed to amend the Credit Agreement as described under Section 2 to reflect the status of Successor Holdings as a public company. 

NOW, THEREFORE, the parties hereto hereby agree as follows: 

SECTION 1. Defined Terms. Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Credit
Agreement after giving effect to the Amendments (as defined below) (the “Amended Credit Agreement”). 
 SECTION 2.
Amendments. The following sections or portions of the Credit Agreement are hereby amended as set forth in the following amendments and restatements thereof (the “Amendments”): 

(a) The definition of “Change of Control” in Section 1.01 is hereby amended by (i) replacing paragraph (b) in its
entirety with “[reserved]; or” and (ii) deleting from paragraph (c) the phrase “at any time upon or after the consummation of a Qualified IPO,” and the phrase “or any underwriter participating in a Qualified
IPO” of such definition. 
 (b) Each of the definitions of “Available Amount” (but only clause (b) thereof),
“Consolidated Capital Expenditures” (other than clauses (d) and (k) thereof), “Consolidated Depreciation and Amortization Expense,” “Consolidated EBITDA,” “Consolidated Interest Expense,”
“Consolidated Maintenance Capital Expenditures,” “Consolidated Net Income” (except the last two references to the Borrower in clause (e)), “Consolidated Total Assets,” “Consolidated Total Debt,” “Current

  
 -1- 

 
Assets,” “Current Liabilities,” “Excess Cash Flow” (other than clauses (h) and (m) thereof), “First Lien Leverage Ratio,” “Fixed Charge Coverage
Ratio,” “Immaterial Subsidiary,” “Net Cash Proceeds” (but only part of clause (a) preceding subclause (i) thereof), “Unrestricted Cash” and “Unrestricted Subsidiary” (but only the second proviso
of the first sentence thereof) is hereby amended by replacing (i) the words “the Borrower” with “Holdings” and (ii) the words “other Restricted Subsidiary” or “other Restricted Subsidiaries” with
“Restricted Subsidiary” or “Restricted Subsidiaries”. 
 (c) The following defined terms in Section 1.01 are hereby
amended and restated to read in their entirety as follows: 
  

	 	i.	 “Parent Entity” shall mean any direct or indirect parent of the Borrower, including Holdings.

  

	 	ii.	 “Qualified IPO” shall mean the initial public offering of the Equity Interests of Holdings
that occurred on June 11, 2020. 

 (d) Article V shall be amended by adding the reference “5.04”
immediately after “Sections 5.01(a),” in the last parenthetical in the first paragraph thereof. 
 (e) Section 5.04
shall be amended as follows: 
  

	 	i.	 Paragraph (a) is hereby amended and restated to read in its entirety as follows: 

As soon as available, and in any event not later than five Business Days after the date by which Holdings is required to file its annual report
on Form 10-K with the SEC (after giving effect to any permitted extensions or, if such financial statements are not required to be filed with the SEC, not later than 90 days after the end of such fiscal year),
(i) a consolidated balance sheet and related statements of operations, cash flows and owners’ equity showing the financial position of Holdings and its Subsidiaries as of the close of such fiscal year and the consolidated results of its
operations during such year (the “Annual Financial Statements”); provided that if Holdings includes the financial results of any person that is not a Restricted Subsidiary in such Annual Financial Statements, Holdings shall
also provide a supplement showing consolidating information for Holdings and the Restricted Subsidiaries; (ii) a narrative discussion of management’s discussion and analysis of results; and (iii) setting forth in comparative form the
corresponding figures for the prior fiscal year, which consolidated balance sheet and related statements of operations, cash flows and owners’ equity shall be audited by Holdings’ independent public accountants of recognized national
standing and accompanied by an opinion of such accountants (which shall not be qualified as to scope of audit or as to the status of Holdings or its Subsidiaries as a going concern other than any such qualification or exception that is solely with
respect to, or resulting solely from, an upcoming maturity date under the Credit Facilities or any other Material Indebtedness occurring within one year from the time such report is delivered or any prospective default of any financial covenant) to
the effect that such consolidated financial statements fairly present, in all material respects, the financial position and results of operations of Holdings and its Subsidiaries on a consolidated basis in accordance with GAAP; 

 

	 	ii.	 Paragraph (b) is hereby amended and restated to read in its entirety as follows: 

As soon as available, and in any event not later than five Business Days after the date by which Holdings is required to file its quarterly
report on Form 10-Q with the SEC (after giving effect to any permitted extensions or, if such financial statements are not required to be filed with the SEC, not later than 45 days after the end of such fiscal
quarter), (i) a consolidated balance sheet and 

  
 -2- 

 
related statements of operations and cash flows showing (x) the financial position of Holdings and its Subsidiaries as of the close of such fiscal quarter and the consolidated and
consolidating results of its operations during such fiscal quarter and (y) the then-elapsed portion of the fiscal year and setting forth in comparative form the corresponding figures for the corresponding periods of the prior fiscal year (the
“Quarterly Financial Statements” and, together with the Annual Financial Statements, the “Required Financial Statements”); provided that if Holdings includes the financial results of any person that is not a
Restricted Subsidiary in such Quarterly Financial Statements, Holdings shall also provide a supplement showing consolidating information for Holdings and the Restricted Subsidiaries; and (ii) a narrative discussion of management’s
discussion and analysis of results, certified by a Responsible Officer of Holdings on behalf of Holdings as fairly presenting, in all material respects, the financial position and results of operations of Holdings and its Subsidiaries on a
consolidated basis in accordance with GAAP (subject to normal year-end audit adjustments and the absence of footnotes). 
  

	 	iii.	 Paragraph (c) is hereby replaced in its entirety with “[Reserved];”. 

 

	 	iv.	 Paragraphs (e), (g) and (h) are hereby amended by replacing the words “the Borrower” with
“Holdings”. 

  

	 	v.	 The proviso and the last paragraph at the end of Section 5.04 is hereby amended and restated to read in
its entirety as follows: 

 provided that documents required to be delivered pursuant to paragraphs (a), (b) and
(d) shall be deemed to have been delivered on the earlier of the date on which (A) Holdings posts such documents or provides a link thereto on Holdings’ website, with notification to the Administrative Agent of the posting of such
documents and (B) such documents are filed with the SEC; provided, further, if requested by the Administrative Agent in writing, Holdings shall also provide such documents by electronic mail to the Administrative Agent. 

SECTION 3. Conditions to Effectiveness of the Amendments. This Amendment shall become effective on the date on which the following
conditions precedent have been satisfied or waived (the date on which such conditions shall have been so satisfied or waived, the “First Amendment Effective Date”): 

(a) the Administrative Agent shall have received the Amendment duly executed and delivered by Holdings, the Borrower, the Required Lenders and
the Administrative Agent; and 
 (b) immediately before and after giving effect to the Amendments, the representations and warranties set
forth in Section 4 shall be true and correct on and as of the First Amendment Effective Date. 
 The Administrative Agent shall notify
the Borrower and the Lenders of the First Amendment Effective Date, and such notice shall be conclusive and binding. 
 SECTION 4.
Representations and Warranties. To induce the other parties hereto to enter into this Amendment, the Borrower represents and warrants to each of the Lenders and the Administrative Agent that, as of the First Amendment Effective Date and after
giving effect to this Amendment: 
 (a) The Borrower (i) is a limited liability company duly organized, validly existing and in good
standing (or in any foreign jurisdiction where an equivalent status exists, enjoys the equivalent status under the laws of such foreign jurisdiction of organization) under the laws of the jurisdiction of its organization and (ii) has the power
and authority to execute, deliver and perform its obligations under this Amendment. 

  
 -3- 

 (b) This Amendment has been duly authorized, executed and delivered by the Borrower and
constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms, subject to (i) the effects of bankruptcy, insolvency, moratorium, reorganization, fraudulent conveyance or other similar laws affecting
creditors’ rights generally, (ii) general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law) and (iii) implied covenants of good faith and fair dealing. 

(c) After giving effect to this Amendment and the transactions contemplated hereby on First Amendment Effective Date, no Default or Event of
Default has occurred and is continuing on the First Amendment Effective Date. 
 SECTION 5. Effect on the Loan Documents.
(a) This Amendment shall not extinguish the Term Loans outstanding under the Credit Agreement and nothing herein contained shall be construed as a substitution or novation of the Term Loans outstanding under the Credit Agreement, which shall
remain outstanding after the First Amendment Effective Date, as modified hereby. Except as specifically amended herein, all Loan Documents shall continue to be in full force and effect and are hereby in all respects ratified and confirmed. The
Borrower hereby agrees, with respect to each Loan Document to which it is a party, that all of its obligations, liabilities and indebtedness under such Loan Document shall remain in full force and effect on a continuous basis after giving effect to
this Amendment, the Amendments, and all of the Liens and security interests created and arising under such Loan Document remain in full force and effect on a continuous basis, and the perfected status and priority of each such Lien and security
interest continues in full force and effect on a continuous basis, unimpaired, uninterrupted and undischarged, after giving effect to this this Amendment, the Amendments, as collateral security for its obligations, liabilities and indebtedness under
the Credit Agreement and the other Loan Documents. 
 (b) Upon the First Amendment Effective Date, each reference in the Credit Agreement to
“this Amendment,” “herein,” “hereto,” “hereunder,” “hereof,” or in the other Loan Documents to the “Credit Agreement”, or, in each case, words of like import shall mean and be a reference
to the Amended Credit Agreement; and each reference to “Holdings” shall mean and be a reference to Successor Holdings, as successor-in-interest to Predecessor
Holdings. 
 (c) Except as expressly set forth in this Amendment, the execution, delivery and effectiveness of this Amendment shall not
operate as a waiver of any right, power or remedy of any Lender or the Administrative Agent under any of the Loan Documents, nor constitute a waiver of any provision of any of the Loan Documents. 

(d) The Borrower and the other parties hereto acknowledge and agree that this Amendment shall constitute a Loan Document. 

SECTION 6. Expenses. The Borrower agrees to pay or reimburse the Administrative Agent and the Lenders for all of their reasonable,
documented and invoiced out-of-pocket costs and expenses incurred in connection with this Amendment, any other documents prepared in connection herewith and the
transactions contemplated hereby, including, the reasonable, documented and invoiced fees, charges and disbursements of counsel to the Administrative Agent, all in accordance with and subject to Section 9.05 of the Credit Agreement. 

  
 -4- 

 SECTION 7. GOVERNING LAW; WAIVER OF JURY TRIAL. THIS AMENDMENT AND THE
RIGHTS AND OBLIGATIONS OF THE PARTIES HERETO SHALL BE GOVERNED BY, AND CONSTRUED AND INTERPRETED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. EACH PARTY HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES TRIAL BY JURY IN ANY SUIT,
ACTION, PROCEEDING, CLAIM OR COUNTERCLAIM BROUGHT BY OR ON BEHALF OF ANY PARTY RELATED TO OR ARISING OUT OF THIS AMENDMENT OR ANY OTHER LOAN DOCUMENT AND FOR ANY COUNTERCLAIM THEREIN. 

SECTION 8. Amendments; Execution in Counterparts. This Amendment may not be amended nor may any provision hereof be waived except
pursuant to a writing signed by the Borrower, the Administrative Agent and the Required Lenders in accordance with Section 9.08 of the Credit Agreement. This Amendment may be executed by one or more of the parties to this Amendment on any
number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. Delivery of an executed signature page of this Amendment by email or facsimile transmission shall be effective as
delivery of a manually executed counterpart hereof. 
 [Remainder of page intentionally left blank.] 

  
 -5- 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and
delivered by their respective proper and duly authorized officers as of the day and year first above written. 
  

			
	THE AZEK COMPANY, as Holdings
		
	By:	 	   /s/ Paul Kardish

	Name: Paul Kardish
	Title: Senior Vice President & Chief Legal Officer
	
	CPG INTERNATIONAL LLC, as the Borrower
		
	By:	 	   /s/ Paul Kardish

	Name: Paul Kardish
	Title: Chief Legal Officer

 [First Amendment – Signature Page] 

 
			
	JEFFERIES FINANCE LLC, as Administrative Agent
		
	By:	 	 /s/ Paul Chisholm

	Name: Paul Chisholm
	Title: Managing Director

 [First Amendment – Signature Page] 

 [Lender signature pages intentionally omitted] 

[First Amendment – Signature Page]EX-10.36

 Exhibit 10.36 

THE AZEK COMPANY INC. 

2020 OMNIBUS INCENTIVE COMPENSATION PLAN 

 THE AZEK COMPANY INC. 

2020 OMNIBUS INCENTIVE COMPENSATION PLAN 

ARTICLE I 
 GENERAL

 1.1 Purpose 
 The purpose of The
AZEK Company Inc. 2020 Omnibus Incentive Compensation Plan (as amended from time to time, the “Plan”) is to help the Company (as hereinafter defined): (1) attract, retain and motivate key employees (including prospective
employees) and consultants and non-employee directors of The AZEK Company Inc., a Delaware corporation (“AZEK”); (2) align the interests of such persons with AZEK’s stockholders;
and (3) promote ownership of AZEK’s equity. 
 1.2 Definitions of Certain Terms 

For purposes of this Plan, the following terms have the meanings set forth below: 

1.2.1 “Acquisition Awards” has the meaning set forth in Section 1.6.1. 

1.2.2 “AOT Board” means the Board of Directors of AOT Building Products GP Corp., AZEK’s indirect parent. 

1.2.3 “Award” means an award made pursuant to the Plan. 

1.2.4 “Award Agreement” means the written document by which each Award is evidenced, and which may, but need not be (as
determined by the Committee) executed or acknowledged by a Grantee as a condition to receiving an Award or the benefits under an Award, and which sets forth the terms and provisions applicable to Awards granted under the Plan to such Grantee. Any
reference herein to an agreement in writing will be deemed to include an electronic writing to the extent permitted by applicable law. 

1.2.5 “Board” means the Board of Directors of AZEK. 

1.2.6 “Business Combination” has the meaning provided in the definition of Change in Control. 

1.2.7 “Cause” means (a) with respect to a Grantee employed pursuant to a written employment agreement which
agreement includes a definition of “Cause,” “Cause” as defined in that agreement or (b) with respect to any other Grantee, except as otherwise set forth in an Award Agreement, the occurrence of any of the following:
(i) such Grantee’s conviction of, or plea of guilty or nolo contendere to, any felony or any crime involving fraud, dishonesty or moral turpitude under the laws of the United States or any state thereof or under the laws of any other
jurisdiction, (ii) such Grantee’s attempted commission of, or participation in, a fraud or theft against the Company or any client of the Company, (iii) such Grantee’s engagement in gross misconduct that causes financial or
reputation harm to the Company, (iv) such Grantee’s repeated failure to substantially perform his or her duties and responsibilities to the Company 

 (other than failure resulting from such Grantee’s Disability), (v) such Grantee’s material
violation of any contract or agreement between the Grantee and the Company or any written Company policy or any provision of the Company’s code of business conduct and ethics (including any successor thereto) or any other Company-established
code of conduct to which such Grantee is subject or (vi) such Grantee’s habitual abuse of narcotics. 
 1.2.8
“Certificate” means a stock certificate or other appropriate document or evidence of ownership representing Shares. 

1.2.9 “Change in Control” means, except in connection with any initial public offering of the Common Stock or as
otherwise set forth in an Award Agreement, the occurrence of any of the following events after the completion of the initial public offering of the Company: 

(a) during any period of not more than 36 months, individuals who constitute the Board as of the beginning of the period (the
“Incumbent Directors”) cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to the beginning of such period, whose election or nomination
for election was approved by a vote of at least two-thirds of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of AZEK in which such person is named as
a nominee for director, without written objection to such nomination) will be an Incumbent Director; provided, however, that no individual initially elected or nominated as a director of AZEK as a result of an actual or publicly
threatened election contest with respect to directors or as a result of any other actual or publicly threatened solicitation of proxies or consents by or on behalf of any person other than the Board will be deemed to be an Incumbent Director; 

(b) any “person” (as such term is defined in Section 3(a)(9) of the Exchange Act and as used in Sections 13(d)(3) and
14(d)(2) of the Exchange Act), is or becomes a “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of AZEK representing 50% or more of the
combined voting power of AZEK’s then-outstanding securities eligible to vote for the election of the Board (“Company Voting Securities”); provided, however, that the event described in this
paragraph (b) will not be deemed to be a Change in Control by virtue of the ownership, or acquisition, of Company Voting Securities: (A) by the Company, (B) by any employee benefit plan (or related trust) sponsored or maintained
by the Company, (C) by any underwriter temporarily holding securities pursuant to an offering of such securities or (D) pursuant to a Non-Qualifying Transaction (as defined in paragraph (c) of
this definition); 
 (c) the consummation of a merger, consolidation, statutory share exchange or similar form of corporate transaction
involving AZEK that requires the approval of AZEK’s stockholders, whether for such transaction or the issuance of securities in the transaction (a “Business Combination”), unless immediately following such Business
Combination: (A) more than 50% of the total voting power of (x) the entity resulting from such Business Combination (the “Surviving Entity”), or (y) if applicable, the ultimate parent corporation that directly
or indirectly has beneficial ownership of at least 95% of the voting power, is represented by Company Voting Securities that were outstanding immediately prior to such Business Combination (or, if applicable, is represented by shares into which such
Company Voting Securities were converted pursuant to such Business Combination), and such voting power 

  
 -2- 

 
among the holders thereof is in substantially the same proportion as the voting power of such Company Voting Securities among the holders thereof immediately prior to the Business Combination,
(B) no person (other than any employee benefit plan (or related trust) sponsored or maintained by the Surviving Entity or the parent), is or becomes the beneficial owner, directly or indirectly, of 50% or more of the total voting power of the
outstanding voting securities eligible to elect directors of the parent (or, if there is no parent, the Surviving Entity) and (C) at least a majority of the members of the board of directors of the parent (or, if there is no parent, the
Surviving Entity) following the consummation of the Business Combination were Incumbent Directors at the time of the Board’s approval of the execution of the initial agreement providing for such Business Combination (any Business Combination
which satisfies all of the criteria specified in (A), (B) and (C) of this paragraph (c) will be deemed to be a “Non-Qualifying Transaction”); or 

(d) the consummation of a sale of all or substantially all of AZEK’s assets (other than to any Sponsor or any direct or indirect
Subsidiary or affiliate of any Sponsor or an affiliate of AZEK); or 
 (e) AZEK’s stockholders approve a plan of complete
liquidation or dissolution of AZEK. 
 Notwithstanding the foregoing, a Change in Control will not be deemed to occur solely because any
person acquires beneficial ownership of more than 50% of the Company Voting Securities as a result of the acquisition of Company Voting Securities by the Company which reduces the number of Company Voting Securities outstanding; provided
that if after such acquisition by the Company such person (other than any Sponsor or any direct or indirect Subsidiary or affiliate of any Sponsor) becomes the beneficial owner of additional Company Voting Securities that increases the
percentage of outstanding Company Voting Securities beneficially owned by such person, a Change in Control will then occur. 
 1.2.10
“Code” means the Internal Revenue Code of 1986, as amended from time to time, or any successor thereto, and the applicable rulings and regulations thereunder. 

1.2.11 “Committee” has the meaning set forth in Section 1.3.1. 

1.2.12 “Common Stock” means the Class A common stock of AZEK, par value $0.001 per share, and any other securities
or property issued in exchange therefor or in lieu thereof pursuant to Section 1.6.3. 
 1.2.13
“Company” means AZEK and any Subsidiary, and any successor entity thereto. 
 1.2.14 “Company Voting
Securities” has the meaning provided in the definition of Change in Control. 
 1.2.15 “Consent” has the
meaning set forth in Section 3.3.2. 
 1.2.16 “Consultant” means any individual (other than
a non-employee Director), who is a natural person that provides bona fide consulting or advisory services to the Company, and such services are not in connection with the offer or sale of securities in a
capital-raising transaction, and do not directly or indirectly promote or maintain a market for the registrant’s securities. 

  
 -3- 

 1.2.17 “Covered Person” has the meaning set forth in
Section 1.3.4. 
 1.2.18 “Director” means a member of the Board. 

1.2.19 “Disability” means the Grantee is unable to perform the essential functions of Grantee’s job, with a
reasonable accommodation, due to illness or injury for such duration as entitles Grantee to long-term disability payments under the AZEK plan in which Grantee participates. 

1.2.20 “Effective Date” has the meaning set forth in Section 3.24. 

1.2.21 “Employee” means a regular, active employee, but not including a
non-employee Director. 
 1.2.22 “Employment” means a Grantee’s
performance of services for the Company, as determined by the Committee. The terms “employ” and “employed” will have their correlative meanings. The Committee in its sole discretion may determine (a) whether and when a
Grantee’s leave of absence results in a termination of Employment, (b) whether and when a change in a Grantee’s association with the Company results in a termination of Employment and (c) the impact, if any, of any such leave of
absence or change in association on outstanding Awards. Unless expressly provided otherwise, any references in the Plan or any Award Agreement to a Grantee’s Employment being terminated will include both voluntary and involuntary terminations.

 1.2.23 “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, or any successor
thereto, and the applicable rules and regulations thereunder. 
 1.2.24 “Fair Market Value” means, with respect to a
Share, the closing price reported for the Common Stock on the applicable date as reported on the New York Stock Exchange or, if not so reported, as determined in accordance with a valuation methodology approved by the Committee, unless
determined as otherwise specified herein. For purposes of the grant of any Award, the applicable date will be the trading day on which the Award is granted or, if the date the Award is granted is not a trading day, the trading day immediately prior
to the date the Award is granted. Notwithstanding the foregoing, with respect to a Share underlying any Award granted on the date of the Company’s initial public offering, the Fair Market Value shall be the price offered for a Share in such
initial public offering. For purposes of the exercise of any Award, the applicable date is the date a notice of exercise is received by the Company or, if such date is not a trading day, the trading day immediately following the date a notice of
exercise is received by the Company. 
 1.2.25 “Grantee” means an Employee, Consultant or Director who receives an
Award. 
 1.2.26 “Incentive Stock Option” means a stock option to purchase Shares that is intended to be an
“incentive stock option” within the meaning of Sections 421 and 422 of the Code, as now constituted or subsequently amended, or pursuant to a successor provision of the Code, and which is designated as an Incentive Stock Option in the
applicable Award Agreement. 

  
 -4- 

 1.2.27 “Incumbent Directors” has the meaning provided in the
definition of Change in Control. 
 1.2.28 “Non-Qualifying Transaction” has
the meaning provided in the definition of Change in Control. 
 1.2.29 “Other Stock-Based or Cash-Based Awards” has
the meaning set forth in Section 2.8.1. 
 1.2.30 “Plan” has the meaning set forth in
Section 1.1. 
 1.2.31 “Plan Action” has the meaning set forth in
Section 3.3.1. 
 1.2.32 “Section 409A” means
Section 409A of the Code, including any amendments or successor provisions to that section, and any regulations and other administrative guidance thereunder, in each case as they may be from time to time amended or interpreted through further
administrative guidance. 
 1.2.33 “Securities Act” means the Securities Act of 1933, as amended from time to time,
or any successor thereto, and the applicable rules and regulations thereunder. 
 1.2.34 “Share Limit” has the
meaning set forth in Section 1.6.1. 
 1.2.35 “Shares” means shares of Common Stock. 

1.2.36 “Sponsor” means either of Ares Management Corporation or Ontario Teachers’ Pension Plan Board. 

1.2.37 “Subsidiary” means any corporation, partnership, limited liability company or other legal entity in which AZEK,
directly or indirectly, owns stock or other equity interests possessing 50% or more of the total combined voting power of all classes of the then-outstanding stock or other equity interests. 

1.2.38 “Surviving Entity” has the meaning provided in the definition of Change in Control. 

1.2.39 “Ten Percent Stockholder” means a person owning stock possessing more than 10% of the total combined voting
power of all classes of stock of AZEK and of any Subsidiary or parent corporation of AZEK. 
 1.2.40 “Treasury
Regulations” means the regulations promulgated under the Code by the United States Treasury Department, as amended. 

  
 -5- 

 1.3 Administration 

1.3.1 The Compensation Committee of the Board (as constituted from time to time, and including any successor committee, the
“Committee”) will administer the Plan. In particular, the Committee will have the authority in its sole discretion to: 

(a) exercise all of the powers granted to it under the Plan; 

(b) construe, interpret and implement the Plan and all Award Agreements; 

(c) prescribe, amend and rescind rules and regulations relating to the Plan, including rules governing the Committee’s own operations and,
without limiting the foregoing, to make exceptions to any such rules or regulations if the Committee, in good faith, determines appropriate in light of extraordinary circumstances and for the benefit of the Company and so as to avoid unanticipated
consequences or address unanticipated events (including any temporary closure of an applicable stock exchange, disruption of communications or natural catastrophe); 

(d) make all determinations necessary or advisable in administering the Plan; 

(e) correct any defect, supply any omission and reconcile any inconsistency in the Plan; 

(f) amend the Plan to reflect changes in applicable law; 

(g) grant, or recommend to the Board for approval to grant, Awards and determine who will receive Awards, when such Awards will be granted and
the terms of such Awards, including setting forth provisions with regard to the effect of a termination of Employment on such Awards and conditioning the vesting of, or the lapsing of any applicable vesting restrictions or other vesting conditions
on, Awards upon the attainment of performance goals and/or upon continued service; 
 (h) amend any outstanding Award Agreement in any
respect including, without limitation, to 
 (1) accelerate the time or times at which the Award becomes vested, unrestricted or may be
exercised (and, in connection with such acceleration, the Committee may provide that any Shares acquired pursuant to such Award will be restricted shares, which are subject to vesting, transfer, forfeiture or repayment provisions similar to those in
the Grantee’s underlying Award), 
 (2) accelerate the time or times at which Shares are delivered under the Award (and, without
limitation on the Committee’s rights, in connection with such acceleration, the Committee may provide that any Shares delivered pursuant to such Award will be restricted shares, which are subject to vesting, transfer, forfeiture or repayment
provisions similar to those in the Grantee’s underlying Award), 

  
 -6- 

 (3) waive or amend any goals, restrictions, vesting provisions or conditions set forth in
such Award Agreement, or impose new goals, restrictions, vesting provisions and conditions, subject to Section 3.1 or 

(4) reflect a change in the Grantee’s circumstances (e.g., a change to part-time employment status or a change in position, duties
or responsibilities); and 
 (i) determine at any time whether, to what extent and under what circumstances and method or methods, subject to
Section 3.14, 
 (1) Awards may be 

(A) settled in cash, Shares, other securities, other Awards or other property (in which event, the Committee may specify what other effects
such settlement will have on the Grantee’s Award, including the effect on any repayment provisions under the Plan or Award Agreement), 

(B) exercised or 
 (C) canceled,
forfeited or suspended, 
 (2) Shares, other securities, other Awards or other property and other amounts payable with respect to an Award
may be deferred either automatically or at the election of the Grantee thereof or of the Committee, 
 (3) the exercise price for any stock
option (other than an Incentive Stock Option, unless the Committee determines that such a stock option will no longer constitute an Incentive Stock Option) or stock appreciation right may be reset, subject to Section 2.3.6.

 1.3.2 Actions of the Committee may be taken by the vote of a majority of its members present at a meeting (which may be held
telephonically). Any action may be taken by a written instrument signed by a majority of the Committee members, and action so taken will be as fully effective as if it had been taken by a vote at a meeting. The determination of the Committee on all
matters relating to the Plan or any Award Agreement will be final, binding and conclusive. Subject to applicable law, Committee may allocate among its members and delegate to any person who is not a member of the Committee, or to any administrative
group within the Company, any of its powers, responsibilities or duties. In delegating its authority, the Committee will consider the extent to which any delegation may cause Awards to fail to meet the requirements of Rule 16(b)-3(d)(1) or Rule 16(b)-3(e) under the Exchange Act. Except as specifically provided to the contrary, references to the Committee include any administrative group,
individual or individuals to whom the Committee has delegated its duties and powers. 
 1.3.3 Notwithstanding anything to the contrary
contained herein, the Board may, in its sole discretion, at any time and from time to time, grant Awards or administer the Plan. In any such case, the Board will have all of the authority and responsibility granted to the Committee herein. 

  
 -7- 

 1.3.4 No member of the Committee, person to whom the Committee delegates its powers,
responsibilities or duties in writing, including by resolution or member of the AOT Board (each such person, a “Covered Person”), will have any liability to any person (including any Grantee) for any action taken or omitted
to be taken or any determination made with respect to the Plan or any Award, except as expressly provided by statute. Each Covered Person will be indemnified and held harmless by the Company against and from: 

(a) any loss, cost, liability or expense (including reasonable attorneys’ fees) that may be imposed upon or incurred by such Covered
Person in connection with or resulting from any action, suit or proceeding to which such Covered Person may be a party or in which such Covered Person may be involved by reason of any action taken or omitted to be taken under the Plan or any Award
Agreement, in each case, in good faith and 
 (b) any and all amounts paid by such Covered Person, with the Company’s approval, in
settlement thereof, or paid by such Covered Person in satisfaction of any judgment in any such action, suit or proceeding against such Covered Person. The Company will have the right, at its own expense, to assume and defend any such action, suit or
proceeding and, once the Company gives notice of its intent to assume the defense, the Company will have sole control over such defense with counsel of the Company’s choice. 

The foregoing right of indemnification will not be available to a Covered Person to the extent that a court of competent jurisdiction in a
final judgment or other final adjudication, in either case, not subject to further appeal, determines that the acts or omissions of such Covered Person giving rise to the indemnification claim resulted from such Covered Person’s bad faith,
fraud or willful misconduct. The foregoing right of indemnification will not be exclusive of any other rights of indemnification to which Covered Persons may be entitled under AZEK’s Certificate of Incorporation or Bylaws, in each case, as
amended from time to time, pursuant to any individual indemnification agreements between such Covered Person and the Company, as a matter of law, or otherwise, or any other power that the Company may have to indemnify such persons or hold them
harmless. 
 1.4 Persons Eligible for Awards 

Awards under the Plan may be made to Employees, Consultants and Directors. 

1.5 Types of Awards Under Plan 
 Awards
may be made under the Plan in the form of cash-based or stock-based Awards. Stock-based Awards may be in the form of any of the following, in each case in respect of Common Stock: 

(a) stock options, 
 (b) stock
appreciation rights, 
 (c) restricted shares, 

(d) restricted stock units, 

  
 -8- 

 (e) dividend equivalent rights and 

(f) performance-based or other equity-based or equity-related Awards (as further described in Section 2.8), that the
Committee determines to be consistent with the purposes of the Plan and the interests of the Company. 
 1.6 Shares of Common Stock Available for Awards

 1.6.1 Common Stock Subject to the Plan. Subject to the other provisions of this
Section 1.6, the total number of Shares that may be granted under the Plan will be 15,852,319 (the “Share Limit”). Shares of Common Stock subject to awards that are assumed, converted or substituted
under the Plan as a result of the Company’s acquisition of another company (including by way of merger, combination or similar transaction) (“Acquisition Awards”) will not count against the number of shares that may be
granted under the Plan. Available shares under a stockholder approved plan of an acquired company (as appropriately adjusted to reflect the transaction) may be used for Awards under the Plan and do not reduce the maximum number of shares available
for grant under the Plan, subject to applicable stock exchange requirements. The Shares of Common Stock issued pursuant to Awards granted under this Plan may be Shares that are authorized and unissued or Shares that were reacquired by the Company,
including treasury Shares or Shares purchased in the open market. 
 1.6.2 Replacement of Shares. Shares subject to an
Award that is forfeited (including any restricted shares repurchased by the Company at the same price paid by the Grantee so that such Shares are returned to the Company), expires or is settled for cash (in whole or in part), to the extent of such
forfeiture, expiration or cash settlement will be available for future grants of Awards under the Plan and will be added back in the same number of Shares as were deducted in respect of the grant of such Award. The payment of dividend equivalent
rights in cash in conjunction with any outstanding Awards will not be counted against the Shares available for issuance under the Plan. Shares tendered by a Grantee or withheld by the Company in payment of the exercise price of a stock option or to
satisfy any tax withholding obligation with respect to an Award will be available for future grants of Awards. With respect to Awards of stock-settled share appreciation rights, the Share Limit will be reduced by only the number of Shares actually
delivered upon exercise of such Award. 
 1.6.3 Adjustments. The Committee will: 

(a) adjust the number of Shares authorized pursuant to Section 1.6.1, 

(b) adjust the number of Shares set forth in Section 2.3.2 that can be issued through Incentive Stock Options and

 (c) adjust the terms of any outstanding Awards (including, without limitation, the number of Shares covered by each outstanding Award, the
type of property or securities to which the Award relates and the exercise or strike price of any Award), 

  
 -9- 

 in such manner as it deems appropriate (including, without limitation, by payment of cash)
to prevent the enlargement or dilution of rights, as a result of any increase or decrease in the number of issued Shares (or issuance of shares of stock other than Shares) resulting from a recapitalization, stock split, reverse stock split, stock
dividend, spinoff, split up, combination, reclassification or exchange of Shares, merger, consolidation, rights offering, separation, reorganization or liquidation or any other change in the corporate structure or Shares, including any extraordinary
dividend or extraordinary distribution; provided that no such adjustment may be made if or to the extent that it would cause an outstanding Award to cease to be exempt from, or to fail to comply with, Section 409A. 

1.7 Limits on Compensation to Non-Employee Directors 

No non-employee Director may be granted (in any calendar year) compensation for service as a Director
with a value in excess of $500,000, with the value of any equity-based awards based on the accounting grant date value of such award. The independent members of the Board may make exceptions to this limit for a non-executive chair of the Board, provided that the non-employee Director receiving such additional compensation may not participate in the decision to award such
compensation. 
 ARTICLE II 

AWARDS UNDER THE PLAN 
 2.1 Agreements
Evidencing Awards 
 Each Award granted under the Plan will be evidenced by an Award Agreement that will contain such provisions and
conditions as the Committee deems appropriate. Unless otherwise provided herein, the Committee may grant Awards in tandem with or, subject to Section 3.14, in substitution for or satisfaction of any other Award or Awards
granted under the Plan or any award granted under any other plan of the Company. By accepting an Award pursuant to the Plan, a Grantee thereby agrees that the Award will be subject to all of the terms and provisions of the Plan and the applicable
Award Agreement. 
 2.2 No Rights as a Stockholder 

No Grantee (or other person having rights pursuant to an Award) will have any of the rights of a stockholder of AZEK with respect to
Shares subject to an Award until the delivery of such Shares. Except as otherwise provided in Section 1.6.3, no adjustments will be made for dividends, distributions or other rights (whether ordinary or extraordinary, and
whether in cash, Common Stock, other securities or other property) for which the record date is before the date the Certificates for the Shares are delivered, or in the event AZEK elects to use another system, such as book entries by the transfer
agent, before the date in which such system evidences the Grantee’s ownership of such Shares. 
 2.3 Options 

2.3.1 Grant. Stock options may be granted to eligible recipients in such number and at such times during the term of the Plan as
the Committee may determine. 
 2.3.2 Incentive Stock Options. At the time of grant, the Committee will determine: 

  
 -10- 

 (a) whether all or any part of a stock option granted to an eligible Employee will be an
Incentive Stock Option and 
 (b) the number of Shares subject to such Incentive Stock Option; provided, however, that

 (1) the aggregate Fair Market Value (determined as of the time the option is granted) of the stock with respect to which Incentive Stock
Options are exercisable for the first time by an eligible Employee during any calendar year (under all such plans of AZEK and of any Subsidiary or parent corporation of AZEK) may not exceed $100,000 and 

(2) no Incentive Stock Option (other than an Incentive Stock Option that may be assumed or issued by the Company in connection with a
transaction to which Section 424(a) of the Code applies) may be granted to a person who is not eligible to receive an Incentive Stock Option under the Code. 

The form of any stock option which is entirely or in part an Incentive Stock Option will clearly indicate that such stock option is an
Incentive Stock Option or, if applicable, the number of Shares subject to the Incentive Stock Option. No more than 1,585,232 Shares (as adjusted pursuant to the provisions of Section 1.6.3) that can be delivered
under the Plan may be issued through Incentive Stock Options. Incentive Stock Options may not be granted under the Plan after the tenth anniversary of the date of the Board’s most recent approval. 

2.3.3 Exercise Price. The exercise price per share with respect to each stock option will be determined by the Committee
but, except as otherwise permitted by Section 1.6.3 and except for any Acquisition Awards, may never be less than the Fair Market Value of a share of Common Stock (or, in the case of an Incentive Stock Option granted to a
Ten Percent Stockholder, 110% of the Fair Market Value). Unless otherwise noted in the Award Agreement, the Fair Market Value of the Common Stock will be its Fair Market Value on the date of grant of the Award of stock options. 

2.3.4 Term of Stock Option. In no event will any stock option be exercisable after the expiration of 10 years (or, in the
case of an Incentive Stock Option granted to a Ten Percent Stockholder, 5 years) from the date on which the stock option is granted. 
 2.3.5
Vesting and Exercise of Stock Option and Payment for Shares. A stock option may vest and be exercised at such time or times and subject to such terms and conditions as will be determined by the Committee at the time the stock
option is granted and set forth in the Award Agreement. Subject to any limitations in the applicable Award Agreement, any Shares not acquired pursuant to the exercise of a stock option on the applicable vesting date may be acquired thereafter at any
time before the final expiration of the stock option. 
 To exercise a stock option, the Grantee must give written notice to the Company
specifying the number of Shares to be acquired and accompanied by payment of the full purchase price therefor in cash or by certified or official bank check or in another form as determined by the Committee, which may include: 

  
 -11- 

 (a) personal check, 

(b) Shares, based on the Fair Market Value as of the exercise date, 

(c) any other form of consideration approved by the Company and permitted by applicable law and 

(d) any combination of the foregoing. 

The Committee may also make arrangements for the cashless exercise of a stock option. Any person exercising a stock option will make such
representations and agreements and furnish such information as the Committee may, in its sole discretion, deem necessary or desirable to effect or assure compliance by the Company on terms acceptable to the Company with the provisions of the
Securities Act, the Exchange Act and any other applicable legal requirements. The Committee may, in its sole discretion, also take whatever additional actions it deems appropriate to effect such compliance including, without limitation, placing
legends on share certificates and issuing stop-transfer notices to agents and registrars. If a Grantee so requests, Shares acquired pursuant to the exercise of a stock option may be issued in the name of the Grantee and another jointly with the
right of survivorship. 
 2.3.6 Repricing. Except as otherwise permitted by Section 1.6.3, the Committee shall not,
without the approval of AZEK’s stockholders (a) reduce the exercise price of stock options issued and outstanding under the Plan, (b) amend or cancel a stock option when the exercise price exceeds the Fair Market Value of one share of
Common Stock in exchange for the grant of a substitute Award or repurchase for cash or other consideration, in each case with the effect of reducing the exercise price and except in accordance with Section 3.6, or
(c) take any other action with respect to a stock option that would be treated as a repricing under the rules and regulations of the principal U.S. national securities exchange on which the Common Stock is listed. 

2.4 Stock Appreciation Rights 
 2.4.1
Grant. Stock appreciation rights may be granted to eligible recipients in such number and at such times during the term of the Plan as the Committee may determine. 

2.4.2 Exercise Price. The exercise price per share with respect to each stock appreciation right will be determined by the
Committee but, except as otherwise permitted by Section 1.6.3, may never be less than the Fair Market Value of the Common Stock. Unless otherwise noted in the Award Agreement, the Fair Market Value of the Common Stock will
be its Fair Market Value on the date of grant of the Award of stock appreciation rights. 
 2.4.3 Term of Stock Appreciation
Right. In no event will any stock appreciation right be exercisable after the expiration of 10 years from the date on which the stock appreciation right is granted. 

  
 -12- 

 2.4.4 Vesting and Exercise of Stock Appreciation Right and Delivery of
Shares. Each stock appreciation right may vest and be exercised in such installments as may be determined in the Award Agreement at the time the stock appreciation right is granted. Subject to any limitations in the applicable Award
Agreement, any stock appreciation rights not exercised on the applicable vesting date may be exercised thereafter at any time before the final expiration of the stock appreciation right. 

To exercise a stock appreciation right, the Grantee must give written notice to the Company specifying the number of stock appreciation rights
to be exercised. Upon exercise of stock appreciation rights, Shares, cash or other securities or property, or a combination thereof, as specified by the Committee, equal in value to: 

(a) the excess of: 
 (1) the Fair
Market Value of the Common Stock on the date of exercise over 
 (2) the exercise price of such stock appreciation right 

multiplied by 
 (b) the
number of stock appreciation rights exercised, will be delivered to the Grantee. 
 Any person exercising a stock appreciation right will
make such representations and agreements and furnish such information as the Committee may, in its sole discretion, deem necessary or desirable to effect or assure compliance by the Company on terms acceptable to the Company with the provisions of
the Securities Act, the Exchange Act and any other applicable legal requirements. If a Grantee so requests, Shares purchased may be issued in the name of the Grantee and another jointly with the right of survivorship. 

2.4.5 Repricing. Except as otherwise permitted by Section 1.6.3, the Committee shall not, without the approval of
AZEK’s stockholders (a) reduce the exercise price of stock appreciation rights issued and outstanding under the Plan, (b) amend or cancel a stock appreciation right when the exercise price exceeds the Fair Market Value of one share of
Common Stock in exchange for the grant of a substitute Award or repurchase for cash or other consideration, in each case with the effect of reducing the exercise price and except in accordance with Section 3.6, or
(c) take any other action with respect to a stock stock appreciation right that would be treated as a repricing under the rules and regulations of the principal U.S. national securities exchange on which the Common Stock is listed. 

2.5 Restricted Shares 
 2.5.1
Grants. The Committee may grant or offer for sale restricted shares in such amounts and subject to such terms and conditions as the Committee may determine. Upon the delivery of such shares, the Grantee will have the rights of a
stockholder with respect to the restricted shares, subject to any other restrictions and conditions as the Committee may include in the applicable Award Agreement. Each Grantee of an Award of restricted shares will be issued a Certificate in respect
of such shares, unless the Committee elects to use another system, 

  
 -13- 

 
such as book entries by the transfer agent, as evidencing ownership of such shares. In the event that a Certificate is issued in respect of restricted shares, such Certificate may be registered
in the name of the Grantee, and will, in addition to such legends required by applicable securities laws, bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Award, but will be held by the Company or
its designated agent until the time the restrictions lapse. 
 2.5.2 Right to Vote and Receive Dividends on Restricted
Shares. Each Grantee of an Award of restricted shares will, during the period of restriction, be the beneficial and record owner of such restricted shares and will have full voting rights with respect thereto. Unless the Committee
determines otherwise in an Award Agreement, during the period of restriction, all ordinary cash dividends or other ordinary distributions paid upon any restricted share will be retained by the Company and will be paid to the relevant Grantee
(without interest) when the Award of restricted shares vests and will revert back to the Company if for any reason the restricted share upon which such dividends or other distributions were paid reverts back to the Company (any extraordinary
dividends or other extraordinary distributions will be treated in accordance with Section 1.6.3). 
 2.6 Restricted Stock Units

 The Committee may grant Awards of restricted stock units in such amounts and subject to such terms and conditions as the Committee may
determine. A Grantee of a restricted stock unit will have only the rights of a general unsecured creditor of AZEK, until delivery of Shares, cash or other securities or property is made as specified in the applicable Award Agreement. On the delivery
date specified in the Award Agreement, the Grantee of each restricted stock unit not previously forfeited or terminated will receive one share of Common Stock, cash or other securities or property equal in value to a share of Common Stock or a
combination thereof, as specified by the Committee. 
 2.7 Dividend Equivalent Rights 

The Committee may include in the Award Agreement with respect to any Award that is subject to Section 409A a dividend equivalent right
entitling the Grantee to receive amounts equal to all or any portion of the regular cash dividends that would be paid on the Shares covered by such Award if such Shares had been delivered pursuant to such Award. The grantee of a dividend equivalent
right will have only the rights of a general unsecured creditor of AZEK until payment of such amounts is made as specified in the applicable Award Agreement. In the event such a provision is included in an Award Agreement, the Committee will
determine whether such payments will be made in cash, in Shares or in another form, whether they will be conditioned upon the exercise of the Award to which they relate (subject to compliance with Section 409A), the time or times at which they
will be made, and such other terms and conditions as the Committee will deem appropriate; provided that in no event may such payments be made unless and until the Award to which they relate vests. 

  
 -14- 

 2.8 Performance-Based and Other Stock-Based or Cash-Based Awards 

2.8.1 Grant. The Committee may grant other types of equity-based, equity-related or cash-based Awards (including the grant
or offer for sale of unrestricted Shares, performance share awards, and performance units settled in cash) (“Other Stock-Based or Cash-Based Awards”) in such amounts and subject to such terms and conditions as the Committee
may determine. The terms and conditions set forth by the Committee in the applicable Award Agreement may relate to the achievement of performance goals, as determined by the Committee at the time of grant. Such Awards may entail the transfer of
actual Shares to Award recipients and may include Awards designed to comply with or take advantage of the applicable local laws of jurisdictions other than the United States. 

Performance Criteria. The performance goals may be based on one or more of the following business criteria (either separately or
in combination) with regard to AZEK (or a Subsidiary, division, other operational unit or administrative department of AZEK), or such other performance goal as the Committee determines appropriate: measures of efficiency (including operating
efficiency, productivity ratios or other similar measures); measures of achievement of expense targets, costs reductions, working capital, cash levels or general expense ratios; asset growth; earnings per share or net earnings; enterprise value or
value creation targets; combined net worth; debt to equity ratio; revenues, sales, net revenues or net sales measures; gross profit or operating profit measures (including before or after taxes or other similar measures); investment performance;
income or operating income measures (with or without investment income or income taxes, before or after risk-adjustment, or other similar measures); cash flow; margin; net income, before or after taxes; earnings before interest, taxes, depreciation
and/or amortization; return measures (including return on capital, invested capital, total capital, tangible capital, expenses, tangible expenses, equity, revenue, investment, assets, or net assets or total shareholder return or similar measures);
market share measures; measures of balance sheet achievements (including debt reductions, leverage ratios or other similar measures); increase in the Fair Market Value of Common Stock; changes (or the absence of changes) in the per share or
aggregate Fair Market Value of Common Stock (including total shareholder returns); and number of securities sold and funds from operations. Any of the foregoing performance goals may be measured in absolute terms or relative to historic performance
or the performance of other companies or an index. 
 2.9 Repayment If Conditions Not Met 

If the Committee determines that all terms and conditions of the Plan and a Grantee’s Award Agreement were not satisfied, and that the
failure to satisfy such terms and conditions is material, then the Grantee will be obligated to pay the Company immediately upon demand therefor, (a) with respect to a stock option and a stock appreciation right, an amount equal to the excess
of the Fair Market Value (determined at the time of exercise) of the Shares that were delivered in respect of such exercised stock option or stock appreciation right, as applicable, over the exercise price paid therefor, (b) with respect to
restricted shares, an amount equal to the Fair Market Value (determined at the time such shares became vested) of such restricted shares and (c) with respect to restricted stock units, an amount equal to the Fair Market Value (determined at the
time of delivery) of the Shares delivered with respect to the applicable delivery date, in each case with respect to clauses (a), (b) and (c) of this Section 2.9, without reduction for any amount applied to satisfy
withholding tax or other obligations in respect of such Award. 

  
 -15- 

 2.10 Minimum Vesting 

All Awards (other than cash-based Awards) granted after the date of the Company’s initial public offering shall be subject to a minimum
vesting schedule of at least twelve months following the date of grant of the Award, provided that the following Awards shall not be subject to the foregoing minimum vesting requirement: any (i) Awards granted in connection with the
Company’s initial public offering, (ii) Acquisition Awards granted in connection with awards that are assumed, converted or substituted pursuant to a merger, acquisition or similar transaction entered into by the Company or any of its
Subsidiaries, (iii) Shares delivered in lieu of fully vested cash Awards, (iv) Awards to non-employee Directors that vest on the earlier of the one-year
anniversary of the date of grant and the next annual meeting of stockholders, and (v) any additional Awards the Committee may grant, up to a maximum of five percent of the available share reserve authorized for issuance under the Plan pursuant
to Section 1.6.1 (subject to adjustment under Section 1.6.3); and, provided, further, that the foregoing restriction does not apply to the Committee’s discretion to provide for accelerated exercisability or vesting of any Award,
including in cases of retirement, death, Disability or a Change in Control, in the terms of the Award Agreement or otherwise. 
 ARTICLE
III 
 MISCELLANEOUS 
 3.1
Amendment of the Plan 
 3.1.1 Unless otherwise provided in the Plan or in an Award Agreement, the Board may at any time and from time to
time suspend, discontinue, revise or amend the Plan in any respect whatsoever but, subject to Sections 1.6.3 and 3.7, no such amendment may materially adversely impair the rights of the Grantee of any Award without the Grantee’s consent.
Subject to Sections 1.6.3 and 3.7, an Award Agreement may not be amended to materially adversely impair the rights of a Grantee without the Grantee’s consent. 

3.1.2 Unless otherwise determined by the Board, stockholder approval of any suspension, discontinuance, revision or amendment will be obtained
only to the extent necessary to comply with any applicable laws, regulations or rules of a securities exchange or self-regulatory agency; provided, however, if and to the extent the Board determines it is appropriate for the Plan to
comply with the provisions of Section 422 of the Code, no amendment that would require stockholder approval under Section 422 of the Code will be effective without the approval of AZEK’s stockholders. 

3.2 Tax Withholding 
 Grantees will be
solely responsible for any applicable taxes (including, without limitation, income and excise taxes) and penalties, and any interest that accrues thereon, that they incur in connection with the receipt, vesting or exercise of any Award. As a
condition to the delivery of any Shares, cash or other securities or property pursuant to any Award or the lifting or lapse of restrictions on any Award, or in connection with any other event that gives rise to a federal or other governmental tax
withholding obligation on the part of the Company relating to an Award (including, without limitation, the Federal Insurance Contributions Act (FICA) tax), 

  
 -16- 

 (a) the Company may deduct or withhold (or cause to be deducted or withheld) from any
payment or distribution to a Grantee whether or not pursuant to the Plan (including Shares otherwise deliverable), 
 (b) the Committee will
be entitled to require that the Grantee remit cash to the Company (through payroll deduction or otherwise) or 
 (c) the Company may enter
into any other suitable arrangements to withhold, in each case in the Company’s discretion, amounts of such taxes required by law to be withheld, based upon the minimum required tax withholding rate for the Grantee (or such other rate that will
not cause an adverse accounting consequence or cost). 
 3.3 Required Consents and Legends 

3.3.1 If the Committee at any time determines that any Consent (as hereinafter defined) is necessary or desirable as a condition of, or in
connection with, the granting of any Award, the delivery of Shares or the delivery of any cash, securities or other property under the Plan, or the taking of any other action thereunder (each such action a “Plan Action”),
then, subject to Section 3.14 such Plan Action will not be taken, in whole or in part, unless and until such Consent will have been effected or obtained to the full satisfaction of the Committee. The Committee may direct
that any Certificate evidencing Shares delivered pursuant to the Plan will bear a legend setting forth such restrictions on transferability as the Committee may determine to be necessary or desirable, and may advise the transfer agent to place a
stop transfer order against any legended shares. 
 3.3.2 The term “Consent” as used in this Article III with respect
to any Plan Action includes: 
 (a) any and all listings, registrations or qualifications in respect thereof upon any securities exchange or
under any federal, state, or local law, or law, rule or regulation of a jurisdiction outside the United States, 
 (b) any and all written
agreements and representations by the Grantee with respect to the disposition of Shares, or with respect to any other matter, which the Committee may deem necessary or desirable to comply with the terms of any such listing, registration or
qualification or to obtain an exemption from the requirement that any such listing, qualification or registration be made, 
 (c) any and all
other consents, clearances and approvals in respect of a Plan Action by any governmental or other regulatory body or any stock exchange or self-regulatory agency, 

  
 -17- 

 (d) any and all consents by the Grantee to: 

(i) the Company’s supplying to any third party recordkeeper of the Plan such personal information as the Committee deems advisable to
administer the Plan, 
 (ii) the Company’s deducting amounts from the Grantee’s wages, or another arrangement satisfactory to the
Committee, to reimburse the Company for advances made on the Grantee’s behalf to satisfy certain withholding and other tax obligations in connection with an Award and 

(iii) the Company’s imposing sales and transfer procedures and restrictions and hedging restrictions on Shares delivered under the Plan
and 
 (e) any and all consents or authorizations required to comply with, or required to be obtained under, applicable local law or
otherwise required by the Committee. Nothing herein will require the Company to list, register or qualify the Shares on any securities exchange. 
 3.4
Right of Offset 
 The Company will have the right to offset against its obligation to deliver Shares (or other property or cash) under
the Plan or any Award Agreement any outstanding amounts (including, without limitation, travel and entertainment or advance account balances, loans, repayment obligations under any Awards, or amounts repayable to the Company pursuant to tax
equalization, housing, automobile or other employee programs) that the Grantee then owes to the Company and any amounts the Committee otherwise deems appropriate pursuant to any tax equalization policy or agreement. Notwithstanding the foregoing, if
an Award provides for the deferral of compensation within the meaning of Section 409A, the Committee will have no right to offset against its obligation to deliver Shares (or other property or cash) under the Plan or any Award Agreement if such
offset could subject the Grantee to the additional tax imposed under Section 409A in respect of an outstanding Award. 
 3.5 Nonassignability; No
Hedging 
 Unless otherwise provided in an Award Agreement or written Company policy, or with the consent of the Committee in its sole
discretion, no Award (or any rights and obligations thereunder) granted to any person under the Plan may be sold, exchanged, transferred, assigned, pledged, hypothecated or otherwise disposed of or hedged, in any manner (including through the use of
any cash-settled instrument), whether voluntarily or involuntarily and whether by operation of law or otherwise, other than by will or by the laws of descent and distribution, and all such Awards (and any rights thereunder) will be exercisable
during the life of the Grantee only by the Grantee or the Grantee’s legal representative. Any sale, exchange, transfer, assignment, pledge, hypothecation, or other disposition in violation of the provisions of this
Section 3.5 will be null and void and any Award which is hedged in any manner will immediately be forfeited. All of the terms and conditions of the Plan and the Award Agreements will be binding upon any permitted successors
and assigns. 

  
 -18- 

 3.6 Change in Control 

3.6.1 Unless the Committee determines otherwise or as otherwise provided in the applicable Award Agreement or Grantee’s written employment
agreement, if a Grantee’s Employment is terminated by the Company or any successor entity thereto without Cause on or within one (1) year after a Change in Control, (a) each Award granted to such Grantee prior to such Change in
Control will become fully vested (including the lapsing of all restrictions and conditions) and, as applicable, exercisable and (b) any Shares deliverable pursuant to restricted stock units will be delivered promptly (but no later than
15 days) following such Grantee’s termination of Employment. As of the Change in Control date, any outstanding performance-based awards shall be deemed earned at the target level at the date of the Change in Control with respect to all
open performance periods and will cease to be subject to any further performance conditions but will continue to be subject to time-based vesting following the Change in Control in accordance with the original performance period. 

3.6.2 Notwithstanding the foregoing, in the event of a Change in Control, a Grantee’s Award will be treated, to the extent determined by
the Committee to be permitted under Section 409A, in accordance with one or more of the following methods as determined by the Committee in its sole discretion: (a) settle such Awards for an amount (as determined in the sole discretion of
the Committee) of cash or securities equal to their value, where in the case of stock options and stock appreciation rights, the value of such amount, if any, will be equal to the
in-the-money spread value (if any) of such awards; (b) provide for the assumption of or the issuance of substitute awards that will substantially preserve the
otherwise applicable terms of any affected Awards previously granted under the Plan, as determined by the Committee in its sole discretion; (c) modify the terms of such awards to add events, conditions or circumstances upon which the vesting of
such Awards or lapse of restrictions thereon will accelerate; (d) deem any performance conditions satisfied at target, maximum or actual performance through closing or provide for the performance conditions to continue (as is or as adjusted by
the Committee) after closing or (e) provide that for a period of at least 20 days prior to the Change in Control, any stock options or stock appreciation rights that would not otherwise become exercisable prior to the Change in Control will be
exercisable as to all Shares subject thereto (but any such exercise will be contingent upon and subject to the occurrence of the Change in Control and if the Change in Control does not take place within a specified period after giving such notice
for any reason whatsoever, the exercise will be null and void) and that any stock options or stock appreciation rights not exercised prior to the consummation of the Change in Control will terminate and be of no further force and effect as of the
consummation of the Change in Control. In the event that the consideration paid in the Change in Control includes contingent value rights, earnout or indemnity payments or similar payments, then the Committee will determine if Awards settled under
clause (i) above are (a) valued at closing taking into account such contingent consideration (with the value determined by the Committee in its sole discretion) or (b) entitled to a share of such contingent consideration. For the
avoidance of doubt, in the event of a Change in Control where all stock options and stock appreciation rights are settled for an amount (as determined in the sole discretion of the Committee) of cash or securities, the Committee may, in its sole
discretion, terminate any stock option or stock appreciation right for which the exercise price is equal to or exceeds the per share value of the consideration to be paid in the Change in Control transaction without payment of consideration
therefor. Similar actions to those specified in this Section 3.6.2 may be taken in the event of a merger or other corporate reorganization that does not constitute a Change in Control. 

  
 -19- 

 3.7 No Continued Employment or Engagement; Right of Discharge Reserved 

Neither the adoption of the Plan nor the grant of any Award (or any provision in the Plan or Award Agreement) will confer upon any Grantee any
right to continued Employment, or other engagement, with the Company, nor will it interfere in any way with the right of the Company to terminate, or alter the terms and conditions of, such Employment or other engagement at any time. 

3.8 Nature of Payments 
 3.8.1 Any and all
grants of Awards and deliveries of Common Stock, cash, securities or other property under the Plan will be in consideration of services performed or to be performed for the Company by the Grantee. Awards under the Plan may, in the discretion of the
Committee, be made in substitution in whole or in part for cash or other compensation otherwise payable to a Grantee. Only whole Shares will be delivered under the Plan. Awards will, to the extent reasonably practicable, be aggregated in order to
eliminate any fractional shares. Fractional shares may, in the discretion of the Committee, be forfeited or be settled in cash or otherwise as the Committee may determine. 

3.8.2 All such grants and deliveries of Shares, cash, securities or other property under the Plan will constitute a special discretionary
incentive payment to the Grantee, will not entitle the Grantee to the grant of any future Awards and will not be required to be taken into account in computing the amount of salary or compensation of the Grantee for the purpose of determining any
contributions to or any benefits under any pension, retirement, profit-sharing, bonus, life insurance, severance or other benefit plan of the Company or under any agreement with the Grantee, unless the Company specifically provides otherwise. 

3.9 Non-Uniform Determinations 

3.9.1 The Committee’s determinations under the Plan and Award Agreements need not be uniform and any such determinations may be made by it
selectively among persons who receive, or are eligible to receive, Awards under the Plan (whether or not such persons are similarly situated). Without limiting the generality of the foregoing, the Committee will be entitled, among other things, to
make non-uniform and selective determinations under Award Agreements, and to enter into non-uniform and selective Award Agreements, as to (a) the persons to receive
Awards, (b) the terms and provisions of Awards and (c) whether a Grantee’s Employment has been terminated for purposes of the Plan. 

3.9.2 To the extent the Committee deems it necessary, appropriate or desirable to comply with foreign law or practices and to further the
purposes of the Plan, the Committee may, in its sole discretion and without amending the Plan, (a) establish special rules applicable to Awards to Grantees who are foreign nationals, are employed outside the United States or both and grant
Awards (or amend existing Awards) in accordance with those rules and (b) cause AZEK to enter into an agreement with any local Subsidiary pursuant to which such Subsidiary will reimburse the Company for the cost of such equity incentives. 

  
 -20- 

 3.10 Other Payments or Awards 

Nothing contained in the Plan will be deemed in any way to limit or restrict the Company from making any award or payment to any person under
any other plan, arrangement or understanding, whether now existing or hereafter in effect. 
 3.11 Plan Headings 

The headings in the Plan are for the purpose of convenience only and are not intended to define or limit the construction of the provisions
hereof. 
 3.12 Termination of Plan 

The Board reserves the right to terminate the Plan at any time; provided, however, that in any case, the Plan will
terminate on the day before the tenth anniversary of the Effective Date, and provided further, that all Awards made under the Plan before its termination will remain in effect until such Awards have been satisfied or terminated
in accordance with the terms and provisions of the Plan and the applicable Award Agreements. 
 3.13 Clawback/Recapture Policy 

Awards under the Plan will be subject to any clawback or recapture policy that the Company may adopt from time to time to the extent provided
in such policy and, in accordance with such policy, may be subject to the requirement that the Awards be repaid to the Company after they have been distributed to the Grantee. 

3.14 Section 409A 
 3.14.1 All Awards
made under the Plan that are intended to be “deferred compensation” subject to Section 409A will be interpreted, administered and construed to comply with Section 409A, and all Awards made under the Plan that are intended to be
exempt from Section 409A will be interpreted, administered and construed to comply with and preserve such exemption. The Board and the Committee will have full authority to give effect to the intent of the foregoing sentence. To the extent
necessary to give effect to this intent, in the case of any conflict or potential inconsistency between the Plan and a provision of any Award or Award Agreement with respect to an Award, the Plan will govern. 

3.14.2 Without limiting the generality of Section 3.14.1, with respect to any Award made under the Plan that is
intended to be “deferred compensation” subject to Section 409A: 
 (a) any payment due upon a Grantee’s termination of
Employment will be paid only upon such Grantee’s separation from service from the Company within the meaning of Section 409A; 

(b) any payment due upon a Change in Control of the Company will be paid only if such Change in Control constitutes a “change in
ownership” or “change in effective control” within the meaning of Section 409A, and in the event that such Change in Control does not constitute a “change in the ownership” or “change in the effective control”
within the meaning of Section 409A, such Award will vest upon the Change in Control and any payment will be delayed until the first compliant date under Section 409A; 

  
 -21- 

 (c) to the extent necessary to avoid the imposition of taxes under Section 409A, any
such payment to a specified employee (as determined in accordance with Section 409A of the Code) to be made with respect to such Award in connection with such Grantee’s separation from service from the Company within the meaning of
Section 409A (and any other payment that would be subject to the limitations in Section 409A(a)(2)(B) of the Code) will be delayed until six months after such Grantee’s separation from service (or earlier death) in accordance with the
requirements of Section 409A; 
 (d) to the extent necessary to comply with Section 409A, any other securities, other Awards or
other property that the Company may deliver in lieu of Shares in respect of an Award will not have the effect of deferring delivery or payment beyond the date on which such delivery or payment would occur with respect to the Shares that would
otherwise have been deliverable (unless the Committee elects a later date for this purpose in accordance with the requirements of Section 409A); 

(e) with respect to any required Consent described in Section 3.3 or the applicable Award Agreement, if such Consent
has not been effected or obtained as of the latest date provided by such Award Agreement for payment in respect of such Award and further delay of payment is not permitted in accordance with the requirements of Section 409A, such Award or
portion thereof, as applicable, will be forfeited and terminate notwithstanding any prior earning or vesting; 
 (f) if the Award includes a
“series of installment payments” (within the meaning of Section 1.409A-2(b)(2)(iii) of the Treasury Regulations), the Grantee’s right to the series of installment payments will be treated
as a right to a series of separate payments and not as a right to a single payment; 
 (g) if the Award includes “dividend
equivalents” (within the meaning of Section 1.409A-3(e) of the Treasury Regulations), the Grantee’s right to the dividend equivalents will be treated separately from the right to other amounts
under the Award; and 
 (h) for purposes of determining whether the Grantee has experienced a separation from service from the Company within
the meaning of Section 409A, “subsidiary” will mean a corporation or other entity in a chain of corporations or other entities in which each corporation or other entity, starting with AZEK, has a controlling interest in another
corporation or other entity in the chain, ending with such corporation or other entity. For purposes of the preceding sentence, the term “controlling interest” has the same meaning as provided in
Section 1.414(c)-2(b)(2)(i) of the Treasury Regulations, provided that the language “at least 20 percent” is used instead of “at least 80 percent” each place it appears
in Section 1.414(c)-2(b)(2)(i) of the Treasury Regulations. 

  
 -22- 

 3.15 Section 280G 

In the event that any payments or benefits otherwise payable to a Grantee (1) constitute “parachute payments” within the meaning
of Section 280G of the Code, and (2) but for this Section 3.15, would be subject to the excise tax imposed by Section 4999 of the Code, then such payments and benefits will be either (x) delivered in
full, or (y) delivered as to such lesser extent that would result in no portion of such payments and benefits being subject to excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the
applicable federal, state and local income and employment taxes and the excise tax imposed by Section 4999 of the Code (and any equivalent state or local excise taxes), results in the receipt by Grantee on an
after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such payments and benefits may be taxable under Section 4999 of the Code. Any determination required under
this Section 3.15 will be made in writing by a nationally-recognized firm selected by the Company, whose determination will be conclusive and binding upon the Grantee. Any reduction in payments and/or benefits required by
this provision will occur in the following order: (1) reduction of cash payments; (2) reduction of vesting acceleration of equity awards; and (3) reduction of other benefits paid or provided to the Grantee. In the event that
acceleration of vesting of equity awards under the Plan is to be reduced, such acceleration of vesting will be cancelled in the reverse order of the date of grant for equity awards. If two or more equity awards are granted on the same date, each
award will be reduced on a pro-rata basis. 
 3.16 Governing Law 

THE PLAN AND ALL AWARDS MADE AND ACTIONS TAKEN THEREUNDER WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
DELAWARE, WITHOUT REFERENCE TO PRINCIPLES OF CONFLICT OF LAWS. 
 3.17 Disputes; Choice of Forum 

3.17.1 The Company and each Grantee, as a condition to such Grantee’s participation in the Plan, hereby irrevocably submit to the
exclusive jurisdiction of the Delaware Court of Chancery, over any suit, action or proceeding arising out of or relating to or concerning the Plan or, to the extent not otherwise specified in any individual agreement between the Company and the
Grantee, any aspect of the Grantee’s Employment with the Company or the termination of that Employment. The Company and each Grantee, as a condition to such Grantee’s participation in the Plan, acknowledge that the forum designated by this
Section 3.17.1 has a reasonable relation to the Plan and to the relationship between such Grantee and the Company. Notwithstanding the foregoing, nothing herein will preclude the Company from bringing any action or
proceeding in any other court for the purpose of enforcing the provisions of this Section 3.17.1. 
 3.17.2 The
agreement by the Company and each Grantee as to forum is independent of the law that may be applied in the action, and the Company and each Grantee, as a condition to such Grantee’s participation in the Plan, (a) agree to such forum even
if the forum may under applicable law choose to apply non-forum law, (b) hereby waive, to the fullest extent permitted by applicable law, any objection which the Company or such Grantee now or hereafter
may have to personal jurisdiction or to the laying of venue of any such suit, action or proceeding in any court referred to in Section 3.17.1, (c) undertake not to commence any action arising out of or relating to or
concerning the Plan in any forum other than the forum described in this Section 3.17 and (d) agree that, to the fullest extent permitted by applicable law, a final and
non-appealable judgment in any such suit, action or proceeding in any such court will be conclusive and binding upon the Company and each Grantee. 

  
 -23- 

 3.17.3 Each Grantee, as a condition to such Grantee’s participation in the Plan, hereby
irrevocably appoints the Chief Legal Officer of the Company as such Grantee’s agent for service of process in connection with any action, suit or proceeding arising out of or relating to or concerning the Plan, who will promptly advise such
Grantee of any such service of process. 
 3.17.4 Each Grantee, as a condition to such Grantee’s participation in the Plan, agrees to
keep confidential the existence of, and any information concerning, a dispute, controversy or claim described in Section 3.19, except that a Grantee may disclose information concerning such dispute, controversy or claim to
the court that is considering such dispute, controversy or claim or to such Grantee’s legal counsel (provided that such counsel agrees not to disclose any such information other than as necessary to the prosecution or defense of the dispute,
controversy or claim). 
 3.18 Waiver of Jury Trial 

EACH GRANTEE WAIVES ANY RIGHT IT MAY HAVE TO TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED ON, ARISING OUT OF, UNDER OR IN CONNECTION WITH
THE PLAN. 
 3.19 Waiver of Claims 

Each Grantee of an Award recognizes and agrees that before being selected by the Committee to receive an Award the Grantee has no right to any
benefits under the Plan. Accordingly, in consideration of the Grantee’s receipt of any Award hereunder, the Grantee expressly waives any right to contest the amount of any Award, the terms of any Award Agreement, any determination, action or
omission hereunder or under any Award Agreement by the Committee, the Company or the Board, or any amendment to the Plan or any Award Agreement (other than an amendment to the Plan or an Award Agreement to which his or her consent is expressly
required by the express terms of an Award Agreement). Nothing contained in the Plan, and no action taken pursuant to its provisions, will create or be construed to create a trust of any kind or a fiduciary relationship between the Company and any
Grantee. The Plan is not intended to be subject to the Employee Retirement Income Security Act of 1974, as amended (ERISA). 
 3.20 Severability; Entire
Agreement 
 If any of the provisions of the Plan or any Award Agreement is finally held to be invalid, illegal or unenforceable (whether
in whole or in part), such provision will be deemed modified to the extent, but only to the extent, of such invalidity, illegality or unenforceability and the remaining provisions will not be affected thereby; provided that if any of
such provisions is finally held to be invalid, illegal, or unenforceable because it exceeds the maximum scope determined to be acceptable to permit such provision to be enforceable, such provision will be deemed to be modified to the minimum extent
necessary to modify such scope in order to make such provision enforceable hereunder. The Plan and any Award Agreements contain the entire agreement of the parties with respect to the subject matter thereof and supersede all prior agreements,
promises, covenants, arrangements, communications, representations and warranties between them, whether written or oral with respect to the subject matter thereof. 

  
 -24- 

 3.21 No Liability of Company 

Notwithstanding anything to the contrary contained herein, in no event will the Company be liable to a Grantee on account of: (a) an
Award’s failure to (1) qualify for favorable United States or foreign tax treatment or (2) avoid adverse tax treatment under United States or foreign law, including, without limitation, Section 409A, or (b) the non-issuance or sale of Shares as to which the Company has been unable to obtain from any regulatory body having jurisdiction the authority deemed by the Company’s counsel to be necessary to the lawful issuance
and sale of any Shares hereunder. 
 3.22 No Third-Party Beneficiaries 

Except as expressly provided in an Award Agreement, neither the Plan nor any Award Agreement will confer on any person other than the Company
and the Grantee of any Award any rights or remedies thereunder. The exculpation and indemnification provisions of Section 1.3.4 will inure to the benefit of a Covered Person’s estate and beneficiaries and legatees.

 3.23 Successors and Assigns of the Company 

The terms of the Plan will be binding upon and inure to the benefit of the Company and any successor entity, including as contemplated by
Section 3.6. 
 3.24 Date of Adoption and Approval of Stockholders 

The Plan was adopted by the AOT Board on January 24, 2020 and was approved by AZEK’s stockholders on June 11, 2020 (the
“Effective Date”). 

  
 -25-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]